Delivery Order SPE2DB24D1201-SPE2DB24FJATQ
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,229.25 firm fixed-price delivery order is for the XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML medical product. The contract has a period of performance through March 24, 2025, and does not have any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,529.01, is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract has a completion date of February 4, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,344.65, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of October 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
The federal contract award is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products. The contract, valued at $1,428.02, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order with a firm fixed price and has an ultimate completion date of June 18, 2025. AmerisourceBergen Drug Corp is a significant vendor for the DLA, holding...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,024.69, is a Firm Fixed Price Delivery Order for the medical product XYOSTED 50 MG/0.5 ML AUTO-INJ 0.5ML. The contract has an ultimate completion date of March 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,403.31, is for the delivery of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,880.32, is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of November 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
The federal contract award is for the delivery of XYOSTED 100 MG/0.5 ML AUTO-INJ 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,575.18, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024. The contract has a completion date of November 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,785.89 firm fixed-price delivery order is for the supply of XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, a medical product. The contract has an ultimate completion date of November 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The $1,066.64 firm fixed-price delivery order is for the pharmaceutical product XYOSTED 75 MG/0.5 ML AUTO-INJ 0.5ML, with a period of performance through October 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...